Wells Fargo Upgrades Edwards Lifesciences (EW) to Overweight, 'We believe that asymptomatic AS is now a free call option'
Tweet Send to a Friend
(Updated - February 2, 2024 11:40 AM EST)
Wells Fargo analyst Lawrence Biegelsen upgraded Edwards Lifesciences (NYSE: EW) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells Fargo analyst Lawrence Biegelsen upgraded Edwards Lifesciences (NYSE: EW) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
